| 000 | 01168 a2200313 4500 | ||
|---|---|---|---|
| 005 | 20250516060542.0 | ||
| 264 | 0 | _c20120229 | |
| 008 | 201202s 0 0 eng d | ||
| 022 | _a1573-4935 | ||
| 024 | 7 |
_a10.1042/BSR20110068 _2doi |
|
| 040 |
_aNLM _beng _cNLM |
||
| 100 | 1 | _aPérez-Lorenzo, Rolando | |
| 245 | 0 | 0 |
_aTargeted inhibition of BRAF kinase: opportunities and challenges for therapeutics in melanoma. _h[electronic resource] |
| 260 |
_bBioscience reports _cFeb 2012 |
||
| 300 |
_a25-33 p. _bdigital |
||
| 500 | _aPublication Type: Journal Article; Research Support, N.I.H., Extramural; Review | ||
| 650 | 0 | 4 | _aAnimals |
| 650 | 0 | 4 | _aClinical Trials as Topic |
| 650 | 0 | 4 | _aCombined Modality Therapy |
| 650 | 0 | 4 | _aDisease Models, Animal |
| 650 | 0 | 4 | _aDrug Resistance, Neoplasm |
| 650 | 0 | 4 | _aHumans |
| 650 | 0 | 4 |
_aMelanoma _xdrug therapy |
| 650 | 0 | 4 |
_aProtein Kinase Inhibitors _xpharmacology |
| 650 | 0 | 4 |
_aProto-Oncogene Proteins B-raf _xantagonists & inhibitors |
| 700 | 1 | _aZheng, Bin | |
| 773 | 0 |
_tBioscience reports _gvol. 32 _gno. 1 _gp. 25-33 |
|
| 856 | 4 | 0 |
_uhttps://doi.org/10.1042/BSR20110068 _zAvailable from publisher's website |
| 999 |
_c21215389 _d21215389 |
||